Presentations

08:00

Angiotensin II type I receptor antibodies are associated with retransplantation in liver allografts

Jeyamani Ramachandran (AU)

Bio Abstract

08:10

Early twice-daily dosing of extended-release tacrolimus improves target trough attainment after kidney transplantation: A prospective randomized controlled study

Ziyan Yan (CN)

Bio Abstract

08:20

2026 Update of the Serologic Nomenclature for Factors of the HLA System; its impact in listing Unacceptable HLA antigens and DSA assessment

Marcelo Fernandez Viña (US)

Bio Abstract

08:30

Impact of preformed donor specific antibodies on rejection, allograft survival and mortality in kidney transplant recipients: An Australian registry study

Paayal Naidu (AU)

Bio Abstract

08:35

Evaluating the Impact of Shared Eplets on Cross-Reactivity in Single Antigen Bead Assays Using Customized HLA Bead Panels

Daiki Iwami (JP)

Bio Abstract

08:40

Donor specific antibodies in paediatric liver allograft T cell mediated rejection

Suzan Warner (AU)

Bio Abstract

08:45

Acute Rejection in Pediatric Kidney Transplantation: The Central Role of De Novo Donor-Specific Antibodies and Impact of Targeted Therapy on Graft Outcomes

Alaa Alsaqqa (AE)

Bio Abstract

08:50

Molecular pathological diagnosis and clinical decision-making system based on mRNA expression profile and immunohischemistry in kidney transplantation

Ping Lan (CN)

Bio Abstract